MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$709,171K Accounts receivable, net$126,477K Inventory, net$37,166K Prepaid expenses andother current assets$21,216K Gross carrying value$240,212K Total current assets$894,030K License and acquiredintangibles, net$131,674K Deferred tax assets, net$52,767K Investment in equitysecurities$22,536K Operating leaseright-of-use asset, net$1,935K Property and equipment,net$1,037K Accumulated amortization$108,538K Total assets$1,103,979K Total liabilities andstockholders' equity$1,103,979K Total stockholders'equity$954,268K Total liabilities$149,711K Additional paid-in capital$479,957K Retained earnings$474,188K Common stock, 0.001 parvalue, 200,000,000...$123K Total currentliabilities$147,152K Operating leaseliability, net of current...$2,350K Other non-currentliabilities$209K Accrued expenses andother liabilities$135,950K Accounts payable$11,202K
Balance Sheet
source: myfinsight.com

CATALYST PHARMACEUTICALS, INC. (CPRX)

CATALYST PHARMACEUTICALS, INC. (CPRX)